A Phase 2, Randomized, Double-Blind, Parallel-Group and Placebo-Controlled Pilot Study to Assess the Safety and Efficacy of a New Pain Patch Versus Placebo and No Treatment for the Treatment of Delayed Onset Muscle Soreness (DOMS)
The purpose of this study is to evaluate the analgesic efficacy and safety of a new pain patch compared to placebo and no treatment in subjects experiencing Delayed Onset Muscle Soreness (DOMS).
100 项与 Shanghai Lead Chemical Co., Ltd. 相关的临床结果
0 项与 Shanghai Lead Chemical Co., Ltd. 相关的专利（医药）
100 项与 Shanghai Lead Chemical Co., Ltd. 相关的药物交易
100 项与 Shanghai Lead Chemical Co., Ltd. 相关的转化医学
